Delivery Order SPE2DB24D9144-SPE2DB25FCMSB

Award Date 5/16/25
Potential Completion Date 6/9/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $15,063.78 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a period of performance through February 18, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $10,317.32, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This federal contract award is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency Troop Support Medical. The $2,855.66 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business organization based in Park Ridge, Illinois. The completion date for this contract is March 7, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract (IDV) with the Defense Logistics Agency,...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,427.82 and is a Firm Fixed Price Delivery Order. The award is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through July 10, 2024. DMS Pharmaceutical Group holds a...
This federal contract award is a delivery order for EXPAREL 266 MG/20 ML VIAL 20ML awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,106.30 firm fixed-price contract was issued by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through March 24, 2025. The contract is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,162.30 award is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of August 20, 2024. DMS Pharmaceutical Group holds a $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,507.22 for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of June 2, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded on June 3, 2024, is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $13,036.38 and a completion date of June 25, 2024. This award is a delivery order contract with a firm fixed price pricing type. DMS Pharmaceutical Group Inc....
This federal contract award, valued at $6,162.30, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a completion date of June 3, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,495.90 firm fixed-price delivery order is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. The award is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB25FCMSB
    Delivery Order

This federal contract award is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,507.22 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a completion date of June 9, 2025 and was awarded on May 16, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a range of pharmaceutical products to support military healthcare facilities. This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 8/17/25, 12:57 AM